Payer coverage for Emrosi™ now available for 65% of commercial lives, up from 29% in May 2025 Expanding payer coverage supports the adoption of Emrosi as prescription demand continues to increase ...

Azelaic acid emerges as a versatile skincare solution, effectively targeting acne, rosacea, and hyperpigmentation. Its unique ...